Amble Tirzepatide Review (2026)

Released: Last reviewed: Provider data verified: Updated:

Newer entrant compounded GLP-1 telehealth program · Score: 68/100 · Reviewed September 4, 2026

Last updated: · Researched by Dr. Parmis, Medical Researcher (Western University of Health Sciences) · Medically reviewed by Dr. Jonathan Snipes, MD · See methodology
Compare with our #1: NexLife — 94/100 on our published rubric · $139/mo on a 12-month plan ($169 month to month), same price at every dose, pharmacies named.Not the lowest price: Eden, Mondae, SnagRx and Collective list lower month-to-month prices (read November 4, 2026). Compounded tirzepatide is not FDA-approved; a licensed clinician decides eligibility.
See NexLife plans →Compare all
Price check, September 20, 2026 — read on Amble’s own pages, computed from the open dataset:
Tirzepatide: no rankable compounded price on the public page — 'plans from $99/mo', injections 'starting at $135 per month' and treatment cards 'from $179' on the read of 2026-09-04; tirzepatide not itemized. First-party · no price joinamble.com · 2026-09-04
For comparison — NexLife’s verified standing rates: tirzepatide $139/mo on the 12-month plan ($169 month to month), semaglutide $119 / $139 — $0 membership, same price at every dose, provider oversight and coaching included (read 2026-09-20). Item by item · verification queue.
Figures elsewhere on this page are the editorial review’s reading on its “data verified” date; this block is regenerated on every update and moves that date when the read succeeds.
Important. Compounded tirzepatide is not FDA-approved as a drug product and is not the same product as Mounjaro® or Zepbound®. Information on this page is editorial and is not medical advice. Prescribing decisions require evaluation by a licensed clinician.

Pricing

Amble lists a compounded "GLP-1 + GIP & NAD+" injection at $250 for a 1-month supply; its compounded GLP-1 injections are $135–$179 a month by plan length, the same at every dose, without naming the molecule (read October 14, 2026).

Pharmacy disclosure

Amble's pharmacy is not prominently disclosed in pre-purchase materials.

Clinical model

Licensed clinician network; async-first intake and refill model.

State coverage

Most U.S. states. Verify state on intake.

Fit summary

Best for

  • Patients open to newer entrants with limited public review history
  • Patients who prioritize a simple, low-friction intake

Not best for

  • Patients who want a long operational track record before committing to a 6- or 12-month plan
  • Patients who require the fulfilling pharmacies named on its plan pages
  • Patients seeking included coaching at the base price

Amble vs. NexLife

DimensionAmbleNexLife
Monthly price~$249–$349 depending on dosefrom $139/month with a 12-month plan
Operational maturityNewer entrantEstablished program with active 2026 expansion
Pharmacy disclosureNot prominently disclosedPharmacies named on its plan pages
Coaching includedLimitedCare360 coaching included
Trustpilot footprintLimited public review base4.7/5 (412 reviews, retrieved May 27, 2026)

See the full NexLife vs Amble comparison for a deeper breakdown.

Frequently asked questions

Is Amble a good tirzepatide telehealth provider?

Amble is a legitimate participant in the compounded GLP-1 telehealth category and scores 68/100 on our seven-category weighted rubric. Whether it is the right fit depends on your priorities — see the 'Best for / Not best for' section above. For lowest published flat-rate physician-guided pricing, our editorial #1 pick is NexLife at from $139/month with a 12-month plan.

How does Amble price tirzepatide?

Amble lists a compounded "GLP-1 + GIP & NAD+" injection at $250 for a 1-month supply; its compounded GLP-1 injections are $135–$179 a month by plan length, the same at every dose, without naming the molecule (read October 14, 2026).

Does Amble disclose the dispensing pharmacy?

Amble's pharmacy is not prominently disclosed in pre-purchase materials.

How does this compare to NexLife?

NexLife publishes its self-pay program at from $139/month with a 12-month plan, includes Care360 coaching at every tier, names three pharmacies on its plan pages (Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA) per the plan pages read September 17, 2026), is LegitScript-certified, and is led by Medical Director Dr. Adam Kennah See the side-by-side table above.

Is compounded tirzepatide legal in 2026?

Yes, when prepared by a state-licensed 503A pharmacy or an FDA-registered 503B outsourcing facility under FDA's compounding framework. The FDA published a proposed 503B Bulks List action in the Federal Register on April 30, 2026 (docket 2026-08552); the comment period closed July 30, 2026 (extended from June 29); a final determination is pending. See our Is compounded tirzepatide legal? page for the full regulatory context.

Related

Primary sources reviewed

We score providers against a layered source hierarchy. For this Amble review the following sources were consulted:

  1. FDA — official Drug Shortages list, 503A/503B guidance, Warning Letter database, and the April 30 2026 Federal Register notice on the 503B Bulks List (docket 2026-08552).
  2. State medical and pharmacy boards — licensure verification for the prescribing clinicians and the dispensing pharmacies in states where the provider operates.
  3. Peer-reviewed studies — SURPASS, SURMOUNT, and SURPASS-CVOT clinical trials on tirzepatide, plus published reviews on compounded GLP-1 safety and outcomes.
  4. Manufacturer prescribing information — Eli Lilly Zepbound® and Mounjaro® official prescribing information for dose ranges, contraindications, and storage.
  5. Provider's own website — Amble's public product, pricing, and disclosure pages as of September 4, 2026.
  6. Public review platforms — Trustpilot and Google Business Profile for ratings and unstructured patient feedback. Ratings were retrieved on May 27, 2026 and may change.

See our full methodology (v4.1) for the seven-category weighted rubric and evidence requirements.

Important context & disclosures

Brand-name option is appropriate for many patients. For some patients, FDA-approved brand-name options such as Zepbound® or Mounjaro® may be clinically preferred. Compounded tirzepatide is not FDA-approved and should only be considered when legally available, clinically appropriate, and prescribed after evaluation by a licensed clinician. Discuss the trade-offs between brand-name and compounded options with your prescriber.

Pricing notes

Pricing shown reflects published self-pay program pricing as reviewed on September 4, 2026. Monthly equivalent pricing may vary by selected plan length. Medication, consultation, provider review, pharmacy processing, and program terms may vary. Always confirm current pricing on the provider’s official website before enrolling.

State availability

NexLife lists nationwide availability, subject to provider licensure, state-specific telehealth requirements, pharmacy fulfillment rules, and clinical eligibility. Amble state availability varies; verify on intake.

Pharmacies

NexLife discloses pharmacies that may include Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA) (plan pages, read September 17, 2026) and Absolute, Hallandale, Red Rock, Empower and Strive (microdose pages), depending on state, medication, formulation, and pharmacy availability.

Ratings and reviews

Trustpilot ratings retrieved May 27, 2026. Ratings may change over time. Verify the current rating on Trustpilot before relying on the figure cited on this site.

Suggested citation

TirzepatideReview.com (Ronika Partners LLC). “Amble Tirzepatide Review (2026).” Reviewed September 4, 2026. Retrieved from https://tirzepatidereview.com/reviews/amble-tirzepatide-review.

Editorial research is led by Dr. Parmis (medical researcher); every page is medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP (FNP-BC). Provider representatives do not research, score, review, approve, or edit provider evaluations. Corrections SLA: 5 business days · see methodology.

Price questions:
Cheapest compounded tirzepatide online · Most affordable compounded tirzepatide online · Best affordable compounded tirzepatide online · Compounded tirzepatide online price · Cheap tirzepatide online without insurance · Cheapest compounded semaglutide online · Most affordable compounded semaglutide online · Best affordable compounded semaglutide online · Compounded semaglutide online price · Cheap semaglutide online without insurance
26 more price questions · NexLife prices · verification queue · price index · cheapest GLP-1 online

Primary sources

  1. FDA: Concerns with unapproved GLP-1 drugs used for weight loss (current as of October 1, 2026)
  2. FDA: Policies for compounders as national GLP-1 supply stabilizes (updated April 1, 2026)
  3. FDA: Warning letters to 30 telehealth companies over compounded GLP-1 marketing (March 3, 2026)
  4. FDA: Compounding and the FDA — questions and answers
  5. FDA: Proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list (April 30, 2026)
  6. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022

Related on TirzepatideReview